• The FDA is set to lose 3,500 full-time staff, with cuts impacting food safety and outbreak response divisions.
  • The CDC faces a reduction of 2,400 employees, including nearly half of its Epidemic Intelligence Service.
  • Critics warn the layoffs could weaken public health protections amid ongoing political restructuring efforts.

Major Workforce Reductions at Health Agencies

The Trump administration, in coordination with the Department of Government Efficiency (DOGE) led by Elon Musk, has initiated sweeping layoffs at the FDA and CDC, targeting thousands of positions. The FDA will cut approximately 3,500 full-time staff, with some estimates suggesting up to 3,800 employees could be affected. The reductions span multiple divisions, including those handling food recalls and foodborne illness investigations—a move that has raised alarms among public health experts.

At the CDC, the layoffs represent roughly 18.7% of its workforce, with 2,400 employees set to depart. Among those affected are 135 members of the CDC’s Epidemic Intelligence Service (EIS), a critical unit for disease surveillance and outbreak response. The cuts come as part of a broader push by the administration to streamline federal agencies, but critics argue the reductions could leave gaps in the nation’s public health infrastructure.

Political Backlash and Long-Term Concerns

Democratic lawmakers and health advocates have sharply criticized the layoffs, framing them as a dangerous erosion of institutional expertise. The resignations of key officials, such as FDA Deputy Commissioner for Human Foods Jim Jones, have further fueled concerns. "These cuts aren’t just about trimming fat—they’re hacking into muscle," said one former CDC official, speaking anonymously due to the sensitivity of the matter.

Industry analysts note that the layoffs align with HHS Secretary Robert F. Kennedy Jr.’s aggressive restructuring agenda, but the long-term consequences remain uncertain. With similar cuts at the NIH and other agencies, the administration’s approach signals a dramatic shift in how federal health operations are staffed and funded. As one public health researcher put it, "You can’t dismantle the safety net and expect no fallout."